Dr. William R Mulley, Australia Oral
A randomised controlled trial of intravenous immunoglobulin (IVIg) compared with standard of care for the treatment of chronic active antibody mediated rejection (VIPAR)

Mr. Hector Tejeda, Netherlands Oral
Tissue-resident memory T cells in human kidney transplants have alloreactive potential

Dr. Abhishek Vashisth, India Oral
Graft function stabilisation in chronic AMR: Can Tocilizumab be an option

Prof. Enver Akalin, United States Oral
Not all transplant glomerulopathy related to chronic antibody-mediated rejection

Dr. Erol Demir, Turkey Oral
Desensitization-Resistant Eplet-Specific HLA Antibodies

Dr. Karin Boer, Netherlands Oral
Dynamic release of kidney-derived urinary extracellular vesicles: potential biomarkers for acute rejection in kidney transplantation